Abstract View

Author(s): Mohammed Aabid1, Siddiqui Khalid Aziz Imran Ahmed*2, Ansari Mohammad Arman Mohammad Murtuza3, Tufail Sayyadain Raza Jaweed Ahmed4, Momin Zafar Iqbal Shahzad Ahmad5

Email(s): 1mohammedaabid02@gmail.com

Address:

    Royal College of Pharmaceutical Education and Research, Malegaon Dist. Nashik 423203

Published In:   Volume - 5,      Issue - 9,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5909  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Artificial intelligence (AI) can be found in pharmacy these days and it helps a lot in areas such as drug selection support, personalized treatment, dosage optimization, and the prediction of medication-related risks; the question is: how can these AI-generated suggestions be made comprehensible and reliable to the healthcare professionals? The problem is solved by Explainable Artificial Intelligence (XAI) by supplying explainable features that show the basis of the AI decision. This paper discusses the role of XAI in pharmacy with a special focus on the areas of AI drug recommendations, adverse drug reaction prediction, drug, drug interaction assessment, patient safety, pharmacovigilance, and the interaction between healthcare professional and patients. We reviewed several papers from the literature and found that XAI methods like Local Interpretable Model-Agnostic Explanations (LIME), SHapley Additive exPlanations (SHAP), decision trees, and attention-based approaches have a potential to enhance openness and to enable doctors and nurses to learn about the reasons for the AI predictions and therefore to XAI possibly contribute to more trust, responsibility, clinical judgment, and safe use of AI-assisted prescribing? Despite all the advantages, the challenges are still quite heavy such as the struggle between the desire to have highly accurate prediction and still having explanations understandable to humans, the question of data quality and possible biases, issues of patient confidentiality and data security, absence of common ways to explain things in healthcare, difficulty to connect the system to other tools already in use, the price of the equipment, and the necessity of properly trained doctors and nurses. The next phase should be devoted to the standardized testing of explanations, development of better AI models, combining patient records from different sources, development of legal guidelines, and making the human-AI teamwork efficient. To sum up, XAI offers an opportunity to increase the comprehensibility and usefulness of AI drug recommendation systems while making sure of human control as part of the pharmacy.

Cite this article:
Mohammed Aabid. Explainable AI in Pharmacy: Building Trust in AI-Based Drug Recommendation. IJRPAS, September 2026; 5(9): 147-168.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5909


References not available.

Related Images:



Recent Images



Evaluation of In-Vitro Anti-Diabetic Activity And   Antioxidant Activity In Ethanolic and Hydroalcoholic Extract of leaves of Gymnema Sylvestre
Molecular Docking Approaches in Antibacterial Drug Discovery: Computational Insights into Natural Compounds
In-vitro Evaluation of Anti-Urolithiatic Activity of Hydroalcoholic Extract of Centella asiatica Leaves
Quality by Design (Qbd) Based Method Development and Validation of Trelagliptin Succinate byu RP-HPLC.
Cubosomes: Structure, Preparation Methods, Characterization, and Pharmaceutical Applications
Programmable Oral Drug Delivery Systems: Materials, Device Engineering, Stimuli-Responsive Mechanisms, and Clinical Translation
Biomimetic Nanocarrier for Targeted Drug Delivery: An Integrated Review
From Phosphate Wasting to Targeted Therapy: An Updated Review of FGF23-Mediated Hypophosphatemic Rickets
Nanotechnology-Based Drug Delivery Systems for Alzheimer’s Disease: Emerging Strategies for Blood–Brain Barrier Targeting
Explainable AI in Pharmacy: Building Trust in AI-Based Drug Recommendation

Tags